WARSAW, Ind., March 1, 2017 /PRNewswire/ -- Zimmer Biomet
Holdings, Inc. (NYSE and SIX: ZBH), a global leader in
musculoskeletal healthcare, today announced that its Board of
Directors has approved the payment of a quarterly cash dividend to
stockholders for the first quarter of 2017.
The cash dividend of $0.24 per
share will be paid on or about April 28,
2017 to stockholders of record as of the close of business
on March 31, 2017. Future
declarations of dividends are subject to approval of the Board of
Directors and may be adjusted as business needs or market
conditions change.
About Zimmer Biomet
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global
leader in musculoskeletal healthcare. We design, manufacture and
market orthopaedic reconstructive products; sports medicine,
biologics, extremities and trauma products; office based
technologies; spine, craniomaxillofacial and thoracic products;
dental implants; and related surgical products.
We collaborate with healthcare professionals around the globe to
advance the pace of innovation. Our products and solutions help
treat patients suffering from disorders of, or injuries to, bones,
joints or supporting soft tissues. Together with healthcare
professionals, we help millions of people live better lives.
We have operations in more than 25 countries around the world
and sell products in more than 100 countries. For more information,
visit www.zimmerbiomet.com, or follow Zimmer Biomet on Twitter at
www.twitter.com/zimmerbiomet.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/zimmer-biomet-announces-quarterly-dividend-for-first-quarter-of-2017-300415015.html
SOURCE Zimmer Biomet Holdings, Inc.